Aptorum Group Limited (NASDAQ:APM) Sees Significant Increase in Short Interest

Aptorum Group Limited (NASDAQ:APM) was the target of a large increase in short interest in November. As of November 15th, there was short interest totalling 13,100 shares, an increase of 184.8% from the October 31st total of 4,600 shares. Based on an average trading volume of 32,600 shares, the days-to-cover ratio is currently 0.4 days. Approximately 0.6% of the shares of the stock are short sold.

Aptorum Group Price Performance

Shares of Aptorum Group stock traded down $0.06 during mid-day trading on Friday, reaching $0.65. 11,165 shares of the stock traded hands, compared to its average volume of 678,645. The business has a 50-day moving average of $1.44 and a 200 day moving average of $2.96. Aptorum Group has a fifty-two week low of $0.46 and a fifty-two week high of $17.49.

About Aptorum Group

Aptorum Group Limited, a biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic products for the treatment of infectious diseases and cancer. The company operates in the Therapeutics and Non-Therapeutics segments. Its pipeline products include SACT- 1 for neuroblastoma and other cancer types; SACT-COV19 for the treatment of coronavirus disease; ALS-4 to treat bacterial infections caused by staphylococcus aureus, including MRSA; and ALS-1 to treat viral infections caused by influenza virus A.